Immunic (IMUX) Return on Assets (2014 - 2026)

Immunic has disclosed Return on Assets across 13 years of filings, most recently posting 0.01% for Q1 2026.

• Return on Assets for Q1 2026 came in at 0.01%, up 2.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (up 2.0% YoY), and the FY2025 annual result was 0.03%, down 1.0% from the prior year.
• Return on Assets came in at 0.01% for Q1 2026 at Immunic, up from 0.03% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.01% in Q1 2022 to a low of 0.03% in Q1 2025.
• The 5-year median for Return on Assets is 0.01% (2024), against an average of 0.01%.
• Across the five-year window, Return on Assets slipped 2 bps in 2025 and grew 2 bps in 2026, its largest moves.
• Immunic's Return on Assets stood at 0.01% in 2022, then plunged by 67 bps to 0.02% in 2023, then dropped by 13 bps to 0.02% in 2024, then tumbled by 76 bps to 0.03% in 2025, then surged by 68 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.03% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.